Animal Early human IBD/ulcerative-colitis trials of BPC-157 (PL-14736) reported it as safe with no reported toxicity but these clinical trials were not completed or fully published
In human blood, hydroxo- and methylcobalamin are found in approximately equal proportions
The present study investigated the effect of topical body protective compound (BPC)-157 treatment on skin wound healing, using an alkali burn rat model
Despite the existence of such a simple treatment, doctors in the USA, UK, and other countries consistently deny it to patients with B12 deficiency and pernicious anemia
Once reconstituted, refrigerate (28C) and use within 30 days
Safety and Research Limitations Importantly, No adequate clinical evidence defines safe human exposure, maximum tolerated dose, reproductive toxicity, carcinogenicity, genotoxicity, cardiovascular risk, liver safety, kidney safety, endocrine effects, or drug interactions